FDA Unveils Action Plan For Clinical Trial Demographics
The U.S. Food and Drug Administration on Wednesday released a 27-point action plan aimed at strengthening the demographic makeup of clinical trials performed by drug and device makers, an issue that...To view the full article, register now.
Already a subscriber? Click here to view full article